Which has higher earnings and valuation, EYE or NVST?

Envista has higher revenue and earnings than National Vision. National Vision is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio National Vision $1.99B 0.77 $29.60M $0.57 33.38 Envista $2.72B 1.53 $47M $0.41 62.35

Does the media favor EYE or NVST?

In the previous week, Envista had 4 more articles in the media than National Vision. MarketBeat recorded 6 mentions for Envista and 2 mentions for National Vision. National Vision's average media sentiment score of 1.90 beat Envista's score of 0.65 indicating that National Vision is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment National Vision 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Envista 1 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor EYE or BLCO?

In the previous week, Bausch + Lomb had 5 more articles in the media than National Vision. MarketBeat recorded 7 mentions for Bausch + Lomb and 2 mentions for National Vision. National Vision's average media sentiment score of 1.90 beat Bausch + Lomb's score of 0.56 indicating that National Vision is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment National Vision 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Bausch + Lomb 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer STVN or EYE?

National Vision has a consensus target price of $30.08, indicating a potential upside of 58.13%. Given National Vision's higher possible upside, analysts plainly believe National Vision is more favorable than Stevanato Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Stevanato Group 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 2.83 National Vision 0 Sell rating(s) 5 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.58

Does the media refer more to STVN or EYE?

In the previous week, National Vision had 1 more articles in the media than Stevanato Group. MarketBeat recorded 2 mentions for National Vision and 1 mentions for Stevanato Group. National Vision's average media sentiment score of 1.90 beat Stevanato Group's score of 1.73 indicating that National Vision is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Stevanato Group 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive National Vision 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has better earnings and valuation, EYE or LIVN?

National Vision has higher revenue and earnings than LivaNova. National Vision is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio National Vision $1.99B 0.77 $29.60M $0.57 33.38 LivaNova $1.39B 3.16 -$242.47M $1.95 40.99

Does the media refer more to EYE or LIVN?

In the previous week, LivaNova had 1 more articles in the media than National Vision. MarketBeat recorded 3 mentions for LivaNova and 2 mentions for National Vision. National Vision's average media sentiment score of 1.90 beat LivaNova's score of 1.52 indicating that National Vision is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment National Vision 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive LivaNova 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media prefer MMED or EYE?

In the previous week, MiniMed Group had 2 more articles in the media than National Vision. MarketBeat recorded 4 mentions for MiniMed Group and 2 mentions for National Vision. National Vision's average media sentiment score of 1.90 beat MiniMed Group's score of 0.73 indicating that National Vision is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MiniMed Group 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive National Vision 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

National Vision (EYE) Competitors

$19.02 -0.27 (-1.38%)

As of 10:18 AM Eastern

Compare

EYE vs. NVST, BLCO, STVN, LIVN, and MMED

Should you buy National Vision stock or one of its competitors? MarketBeat compares National Vision with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with National Vision include Envista (NVST), Bausch + Lomb (BLCO), Stevanato Group (STVN), LivaNova (LIVN), and MiniMed Group (MMED). These companies are all part of the "medical equipment" industry.

How does National Vision compare to Envista?

National Vision (NASDAQ:EYE) and Envista (NYSE:NVST) are both medical equipment companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, media sentiment, risk and profitability.

Envista has higher revenue and earnings than National Vision. National Vision is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
National Vision	$1.99B	0.77	$29.60M	$0.57	33.38
Envista	$2.72B	1.53	$47M	$0.41	62.35

Envista has a net margin of 2.41% compared to National Vision's net margin of 2.31%. Envista's return on equity of 7.11% beat National Vision's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
National Vision	2.31%	6.41%	2.81%
Envista	2.41%	7.11%	3.91%

In the previous week, Envista had 4 more articles in the media than National Vision. MarketBeat recorded 6 mentions for Envista and 2 mentions for National Vision. National Vision's average media sentiment score of 1.90 beat Envista's score of 0.65 indicating that National Vision is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
National Vision	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Envista	1 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

National Vision has a beta of 1.04, suggesting that its share price is 4% more volatile than the broader market. Comparatively, Envista has a beta of 0.86, suggesting that its share price is 14% less volatile than the broader market.

National Vision currently has a consensus price target of $30.08, indicating a potential upside of 58.13%. Envista has a consensus price target of $28.54, indicating a potential upside of 11.64%. Given National Vision's stronger consensus rating and higher possible upside, research analysts plainly believe National Vision is more favorable than Envista.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
National Vision	0 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.58
Envista	0 Sell rating(s)	10 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.38

Summary

Envista beats National Vision on 8 of the 14 factors compared between the two stocks.

How does National Vision compare to Bausch + Lomb?

National Vision (NASDAQ:EYE) and Bausch + Lomb (NYSE:BLCO) are both medical equipment companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, media sentiment, dividends, valuation, analyst recommendations and profitability.

In the previous week, Bausch + Lomb had 5 more articles in the media than National Vision. MarketBeat recorded 7 mentions for Bausch + Lomb and 2 mentions for National Vision. National Vision's average media sentiment score of 1.90 beat Bausch + Lomb's score of 0.56 indicating that National Vision is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
National Vision	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Bausch + Lomb	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

National Vision has a beta of 1.04, indicating that its share price is 4% more volatile than the broader market. Comparatively, Bausch + Lomb has a beta of 0.56, indicating that its share price is 44% less volatile than the broader market.

11.1% of Bausch + Lomb shares are held by institutional investors. 2.4% of National Vision shares are held by insiders. Comparatively, 1.5% of Bausch + Lomb shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

National Vision presently has a consensus target price of $30.08, suggesting a potential upside of 58.13%. Bausch + Lomb has a consensus target price of $18.00, suggesting a potential upside of 12.01%. Given National Vision's stronger consensus rating and higher probable upside, equities research analysts clearly believe National Vision is more favorable than Bausch + Lomb.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
National Vision	0 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.58
Bausch + Lomb	1 Sell rating(s)	9 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.21

National Vision has higher earnings, but lower revenue than Bausch + Lomb. Bausch + Lomb is trading at a lower price-to-earnings ratio than National Vision, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
National Vision	$1.99B	0.77	$29.60M	$0.57	33.38
Bausch + Lomb	$5.10B	1.12	-$360M	-$0.62	N/A

National Vision has a net margin of 2.31% compared to Bausch + Lomb's net margin of -4.21%. National Vision's return on equity of 6.41% beat Bausch + Lomb's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
National Vision	2.31%	6.41%	2.81%
Bausch + Lomb	-4.21%	3.60%	1.69%

Summary

National Vision beats Bausch + Lomb on 12 of the 16 factors compared between the two stocks.

How does National Vision compare to Stevanato Group?

Stevanato Group (NYSE:STVN) and National Vision (NASDAQ:EYE) are both medical equipment companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends.

In the previous week, National Vision had 1 more articles in the media than Stevanato Group. MarketBeat recorded 2 mentions for National Vision and 1 mentions for Stevanato Group. National Vision's average media sentiment score of 1.90 beat Stevanato Group's score of 1.73 indicating that National Vision is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Stevanato Group	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
National Vision	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Stevanato Group has higher earnings, but lower revenue than National Vision. National Vision is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stevanato Group	€1.34B	4.49	€158.21M	€0.59	33.72
National Vision	$1.99B	0.77	$29.60M	$0.57	33.38

Stevanato Group has a beta of 0.78, suggesting that its share price is 22% less volatile than the broader market. Comparatively, National Vision has a beta of 1.04, suggesting that its share price is 4% more volatile than the broader market.

Stevanato Group has a net margin of 11.76% compared to National Vision's net margin of 2.31%. Stevanato Group's return on equity of 10.27% beat National Vision's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Stevanato Group	11.76%	10.27%	6.08%
National Vision	2.31%	6.41%	2.81%

National Vision has a consensus target price of $30.08, indicating a potential upside of 58.13%. Given National Vision's higher possible upside, analysts plainly believe National Vision is more favorable than Stevanato Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stevanato Group	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	2 Strong Buy rating(s)	2.83
National Vision	0 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.58

Summary

Stevanato Group beats National Vision on 9 of the 15 factors compared between the two stocks.

How does National Vision compare to LivaNova?

National Vision (NASDAQ:EYE) and LivaNova (NASDAQ:LIVN) are both medical equipment companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, dividends, profitability, institutional ownership, risk and valuation.

LivaNova has a net margin of 7.48% compared to National Vision's net margin of 2.31%. LivaNova's return on equity of 16.48% beat National Vision's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
National Vision	2.31%	6.41%	2.81%
LivaNova	7.48%	16.48%	7.59%

In the previous week, LivaNova had 1 more articles in the media than National Vision. MarketBeat recorded 3 mentions for LivaNova and 2 mentions for National Vision. National Vision's average media sentiment score of 1.90 beat LivaNova's score of 1.52 indicating that National Vision is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
National Vision	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
LivaNova	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

National Vision presently has a consensus price target of $30.08, indicating a potential upside of 58.13%. LivaNova has a consensus price target of $80.75, indicating a potential upside of 1.04%. Given National Vision's higher possible upside, analysts plainly believe National Vision is more favorable than LivaNova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
National Vision	0 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.58
LivaNova	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60

National Vision has a beta of 1.04, indicating that its stock price is 4% more volatile than the broader market. Comparatively, LivaNova has a beta of 0.86, indicating that its stock price is 14% less volatile than the broader market.

National Vision has higher revenue and earnings than LivaNova. National Vision is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
National Vision	$1.99B	0.77	$29.60M	$0.57	33.38
LivaNova	$1.39B	3.16	-$242.47M	$1.95	40.99

97.6% of LivaNova shares are held by institutional investors. 2.4% of National Vision shares are held by company insiders. Comparatively, 0.4% of LivaNova shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

LivaNova beats National Vision on 9 of the 16 factors compared between the two stocks.

How does National Vision compare to MiniMed Group?

MiniMed Group (NASDAQ:MMED) and National Vision (NASDAQ:EYE) are both medical equipment companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, earnings, risk, analyst recommendations, profitability, dividends and valuation.

In the previous week, MiniMed Group had 2 more articles in the media than National Vision. MarketBeat recorded 4 mentions for MiniMed Group and 2 mentions for National Vision. National Vision's average media sentiment score of 1.90 beat MiniMed Group's score of 0.73 indicating that National Vision is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MiniMed Group	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
National Vision	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

National Vision has a net margin of 2.31% compared to MiniMed Group's net margin of 0.00%. National Vision's return on equity of 6.41% beat MiniMed Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MiniMed Group	N/A	N/A	N/A
National Vision	2.31%	6.41%	2.81%

National Vision has lower revenue, but higher earnings than MiniMed Group. MiniMed Group is trading at a lower price-to-earnings ratio than National Vision, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MiniMed Group	$3.10B	1.35	-$190.97M	-$0.68	N/A
National Vision	$1.99B	0.77	$29.60M	$0.57	33.38

19.7% of MiniMed Group shares are owned by institutional investors. 2.2% of MiniMed Group shares are owned by company insiders. Comparatively, 2.4% of National Vision shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

MiniMed Group currently has a consensus price target of $21.33, suggesting a potential upside of 43.09%. National Vision has a consensus price target of $30.08, suggesting a potential upside of 58.13%. Given National Vision's higher probable upside, analysts clearly believe National Vision is more favorable than MiniMed Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.73
National Vision	0 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.58

Summary

National Vision beats MiniMed Group on 9 of the 15 factors compared between the two stocks.

Get National Vision News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EYE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

EYE vs. The Competition

Export

Metric	National Vision	CONS PD Industry	Staples Sector	NASDAQ Exchange
Market Cap	$1.54B	$30.67B	$16.34B	$12.50B
Dividend Yield	N/A	3.22%	3.33%	8.00%
P/E Ratio	33.63	76.63	26.50	24.41
Price / Sales	0.77	1.60	44.20	117.36
Price / Cash	10.92	13.63	13.37	49.36
Price / Book	1.74	11.14	5.95	6.33
Net Income	$29.60M	$1.30B	$668.93M	$330.66M
7 Day Performance	-3.82%	-3.41%	-1.71%	-0.66%
1 Month Performance	2.22%	-1.38%	-2.63%	-0.14%
1 Year Performance	-23.93%	-15.22%	-13.24%	20.16%

National Vision Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
EYE National Vision	3.8165 of 5 stars	$19.02 -1.4%	$30.08 +58.1%	-21.1%	$1.54B	$1.99B	33.63	13,138	News Coverage Positive News
NVST Envista	2.4352 of 5 stars	$27.08 -1.6%	$28.67 +5.8%	+29.9%	$4.42B	$2.72B	66.28	12,000
BLCO Bausch + Lomb	3.7159 of 5 stars	$17.19 +0.2%	$17.83 +3.7%	+17.1%	$6.14B	$5.10B	N/A	13,000
STVN Stevanato Group	2.747 of 5 stars	€19.39 +0.6%	N/A	-21.4%	€5.86B	€1.20B	32.81	6,010
LIVN LivaNova	1.8399 of 5 stars	$83.60 -0.5%	$80.75 -3.4%	+87.2%	$4.61B	$1.39B	43.03	3,300	News Coverage Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:EYE) was last updated on 7/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

National Vision (EYE) Competitors

EYE vs. NVST, BLCO, STVN, LIVN, and MMED

How does National Vision compare to Envista?

Summary

How does National Vision compare to Bausch + Lomb?

Summary

How does National Vision compare to Stevanato Group?

Summary

How does National Vision compare to LivaNova?

Summary

How does National Vision compare to MiniMed Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EYE vs. The Competition

National Vision Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

National Vision (EYE) Competitors

EYE vs. NVST, BLCO, STVN, LIVN, and MMED

How does National Vision compare to Envista?

Which has higher earnings and valuation, EYE or NVST?

Is EYE or NVST more profitable?

Does the media favor EYE or NVST?

Which has more volatility & risk, EYE or NVST?

Do analysts recommend EYE or NVST?

Summary

How does National Vision compare to Bausch + Lomb?

Does the media favor EYE or BLCO?

Which has more volatility & risk, EYE or BLCO?

Do insiders and institutionals have more ownership in EYE or BLCO?

Do analysts prefer EYE or BLCO?

Which has higher valuation & earnings, EYE or BLCO?

Is EYE or BLCO more profitable?

Summary

How does National Vision compare to Stevanato Group?

Does the media refer more to STVN or EYE?

Which has higher earnings and valuation, STVN or EYE?

Which has more risk & volatility, STVN or EYE?

Is STVN or EYE more profitable?

Do analysts prefer STVN or EYE?

Summary

How does National Vision compare to LivaNova?

Is EYE or LIVN more profitable?

Does the media refer more to EYE or LIVN?

Do analysts prefer EYE or LIVN?

Which has more risk & volatility, EYE or LIVN?

Which has better earnings and valuation, EYE or LIVN?

Do insiders and institutionals believe in EYE or LIVN?

Summary

How does National Vision compare to MiniMed Group?

Does the media prefer MMED or EYE?

Is MMED or EYE more profitable?

Which has better earnings & valuation, MMED or EYE?

Do institutionals & insiders hold more shares of MMED or EYE?

Do analysts rate MMED or EYE?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EYE vs. The Competition

National Vision Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools